MDGLNasdaqPharmaceutical PreparationsFiscal year ends December 31
MADRIGAL PHARMACEUTICALS, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$447.09−2.65 (-0.59%)
Close on Oct 19, 2026
- Market cap
- $13.03B
- P/E (TTM)
- –
- Dividend yield
- –
Fundamental chart
Pick a measure to chart its full history
$958.40MFY2025, +96.5% a year since FY2012